Table of Contents 3
List of Tables 5
List of Figures 5
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
UroGen Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 10
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
UroGen Pharma Acquires All Intellectual Property Assets From Telormedix 12
Venture Financing 13
TheraCoat to Raise USD20 Million in Venture Financing 13
TheraCoat Raises US$7 Million In Venture Financing 14
Licensing Agreements 15
Allergan Enters Into Licensing Agreement With UroGen Pharma 15
Equity Offering 16
UroGen Pharma Raises USD69 Million in Public Offering of Shares 16
UroGen Pharma Raises USD67 Million in IPO 18
UroGen Pharmaceuticals Ltd - Key Competitors 20
UroGen Pharmaceuticals Ltd - Key Employees 21
UroGen Pharmaceuticals Ltd - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 14, 2018: UroGen Pharma reports second quarter 2018 financial results and recent corporate developments 23
Aug 08, 2018: UroGen Pharma appoints Peter P. Pfreundschuh as Chief Financial Officer 25
May 15, 2018: UroGen Pharma Reports First Quarter 2018 Financial Results and Recent Corporate Developments 26
Nov 14, 2017: UroGen Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Developments 27
Corporate Communications 28
Sep 11, 2018: UroGen Pharma names Jones “Woody” Bryan as Senior Vice President of Business Development 28
Jul 10, 2018: UroGen Pharma Appoints Shawn Cline Tomasello to its Board of Directors 29
Feb 14, 2018: UroGen Pharma Strengthens Management Team with the Appointment of Stephen Mullennix as COO 30
Dec 12, 2017: UroGen Pharma Expands Clinical Development Leadership Team 31
Nov 02, 2017: UroGen Pharma Appoints Former Kite Pharma Chief Operating Officer Cynthia M. Butitta to its Board of Directors 32
May 16, 2017: UroGen Pharma Appoints Fred E. Cohen, MD, to its Board of Directors 33
Apr 24, 2017: UroGen Pharma Welcomes New Board Member Kate Falberg 34
Product News 35
05/11/2017: UroGen Pharma Announces Data Presentation Related to its Clinical Stage Uro-Oncology Candidate VesiGel at the American Urology Association 2017 Annual Meeting 35
05/11/2017: UroGen Pharma Announces Data Presentation Related to its Clinical Stage Uro-Oncology Candidate Vesimune at the American Urology Association 2017 Annual Meeting 36
Clinical Trials 37
Apr 03, 2018: UroGen Pharma Announces Presentation of Results from Interim Analysis of Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC) 37
Nov 27, 2017: UroGen Pharma Announces Oral Presentation at Society of Urologic Oncology (SUO) Annual Meeting 38
Aug 29, 2017: UroGen Pharma Receives FDA Fast Track Designation for MitoGel for the Treatment of Upper Tract Urothelial Carcinoma (UTUC) 39
Apr 03, 2017: UroGen Pharma Announces Enrollment of First Patient in Phase 3 Clinical Trial of MitoGel for Treatment of Low-Grade Upper Tract Urothelial Carcinoma 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
UroGen Pharmaceuticals Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
UroGen Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 10
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
UroGen Pharma Acquires All Intellectual Property Assets From Telormedix 12
TheraCoat to Raise USD20 Million in Venture Financing 13
TheraCoat Raises US$7 Million In Venture Financing 14
Allergan Enters Into Licensing Agreement With UroGen Pharma 15
UroGen Pharma Raises USD69 Million in Public Offering of Shares 16
UroGen Pharma Raises USD67 Million in IPO 18
UroGen Pharmaceuticals Ltd, Key Competitors 20
UroGen Pharmaceuticals Ltd, Key Employees 21
UroGen Pharmaceuticals Ltd, Subsidiaries 22

List of Figures
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
UroGen Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
UroGen Pharmaceuticals Ltd, Medical Devices Deals, 2012 to YTD 2018 10